FDA finalized efforts to streamline the process used by physicians to request expanded access, often called compassionate use, to investigational drugs and biologics, as well as two guidance documents. “As a physician, I understand the importance of being able to access investigational treatments for a patient when there are no other options to treat their...
A curious piece of paper hangs in a frame outside the director’s office at University of Iowa Holden Comprehensive Cancer Center on the second floor of the General Hospital.
